BioDelivery Sciences (BDSI) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	44.68M
Accounts receivable, other	3.09M
Prepaid expenses and other current assets	4.47M
Total current assets	56.26M
Equipment, net	4.25M
Goodwill	2.72M
Licenses
Acquired product rights
Accumulated amortization
Total other intangible assets	2.53M
Derivative asset, warrant (note 6)
Other assets
Total assets	65.76M
Accounts payable and accrued liabilities, other
Deferred revenue, current	1.92M
Derivative liabilities (note 6)	100K
Total current liabilities	32.31M
Deferred revenue, long-term	20M
Total liabilities	70.86M
Commitments and contingencies	0
Common Stock, $.001 par value; 45,000,000 shares authorized, 29,577,146 and 24,038,445 shares issued; 29,561,655 and 24,022,954 shares outstanding in 2011 and 2010, respectively	54K
Additional paid-in capital	289.29M
Treasury stock, at cost, 15,491 shares, 2011 and 2010	-47K
Accumulated deficit	-294.4M
Total stockholders' equity	-5.1M
Total liabilities and stockholders' equity	65.76M

Entities mentioned with BDSI

View All Entities